SG/CALL/SARTORIUS STEDIM BIO/290/0.025/20.12.24 Share Price

Warrant

1996S

DE000SU55EM6

Real-time Euronext Paris 15:59:00 14/05/2024 BST
0.285 EUR +16.33% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/290/0.025/20.12.24
Current month-5.77%
1 month-68.59%
Date Price Change
14/05/24 0.285 +16.33%
13/05/24 0.245 -3.92%
10/05/24 0.255 -3.77%
09/05/24 0.265 +3.92%
08/05/24 0.255 -7.27%

Real-time Euronext Paris

Last update May 14, 2024 at 03:59 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
1996S
ISINDE000SU55EM6
Date issued 21/12/2023
Strike 290
Maturity 20/12/2024 (220 Days)
Parity 40 : 1
Emission price 0.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.225
Delta0.28x
Omega 5.166
Premium42.3x
Gearing18.58x
Moneyness 0.7303
Difference Strike 78.3
Difference Strike %+27.00%
Spread 0.01
Spread %3.45%
Theoretical value 0.2850
Implied Volatility 48.31 %
Total Loss Probability 83.24 %
Intrinsic value 0.000000
Present value 0.2850
Break even 301.40 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. 1996S Warrant